Jörgen Lehmann

1.1k total citations
25 papers, 333 citations indexed

About

Jörgen Lehmann is a scholar working on Molecular Biology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Jörgen Lehmann has authored 25 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Psychiatry and Mental health. Recurrent topics in Jörgen Lehmann's work include Bipolar Disorder and Treatment (5 papers), Analytical Chemistry and Chromatography (4 papers) and Tryptophan and brain disorders (4 papers). Jörgen Lehmann is often cited by papers focused on Bipolar Disorder and Treatment (5 papers), Analytical Chemistry and Chromatography (4 papers) and Tryptophan and brain disorders (4 papers). Jörgen Lehmann collaborates with scholars based in Sweden and United Kingdom. Jörgen Lehmann's co-authors include G. D'Elia, Björn Sjögren, H Ekman, J. M. Webber, Jan Wålinder, K. Buck, Ingrid Ernest, L. Wallin and A. B. Foster and has published in prestigious journals such as The Lancet, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jörgen Lehmann

23 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörgen Lehmann Sweden 10 88 69 65 58 53 25 333
J. K. Binns United Kingdom 8 122 1.4× 172 2.5× 103 1.6× 95 1.6× 59 1.1× 10 444
E. Garelis Canada 9 158 1.8× 232 3.4× 57 0.9× 55 0.9× 89 1.7× 16 454
P. L. Morselli Italy 15 106 1.2× 233 3.4× 78 1.2× 28 0.5× 97 1.8× 27 638
N Aymard France 11 81 0.9× 95 1.4× 56 0.9× 30 0.5× 21 0.4× 31 332
A. A. Kurland United States 10 78 0.9× 193 2.8× 68 1.0× 24 0.4× 24 0.5× 23 497
O Varoquaux France 12 71 0.8× 103 1.5× 87 1.3× 34 0.6× 17 0.3× 23 393
A. Barkai United States 13 70 0.8× 159 2.3× 44 0.7× 26 0.4× 18 0.3× 32 579
H.C. Stancer Canada 12 88 1.0× 123 1.8× 33 0.5× 43 0.7× 8 0.2× 24 446
Hans Kvande Sweden 10 34 0.4× 218 3.2× 34 0.5× 30 0.5× 110 2.1× 13 397
I. Gottfries Sweden 7 110 1.3× 177 2.6× 93 1.4× 71 1.2× 115 2.2× 10 483

Countries citing papers authored by Jörgen Lehmann

Since Specialization
Citations

This map shows the geographic impact of Jörgen Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörgen Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörgen Lehmann more than expected).

Fields of papers citing papers by Jörgen Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörgen Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörgen Lehmann. The network helps show where Jörgen Lehmann may publish in the future.

Co-authorship network of co-authors of Jörgen Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jörgen Lehmann. A scholar is included among the top collaborators of Jörgen Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörgen Lehmann. Jörgen Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehmann, Jörgen. (2015). Twenty Years Afterward. American Review of Respiratory Disease. 1 indexed citations
2.
Lehmann, Jörgen. (1982). Tryptophan deficiency stupor--a new psychiatric syndrome.. PubMed. 300. 1–57. 29 indexed citations
3.
D'Elia, G., et al.. (1979). Bimodal distribution of serum tryptophan level. Acta Psychiatrica Scandinavica. 60(1). 10–16. 4 indexed citations
4.
Lehmann, Jörgen, et al.. (1978). Influence of tryptophan on memory functions in depressive patients treated with unilateral ECT. Acta Psychiatrica Scandinavica. 57(3). 259–268. 8 indexed citations
5.
D'Elia, G., et al.. (1977). Evaluation of the combination of tryptophan and ECT in the treatment of depression. Acta Psychiatrica Scandinavica. 56(4). 303–318. 27 indexed citations
6.
D'Elia, G., et al.. (1977). Evaluation of the combination of tryptophan and ECT in the treatment of depression. Acta Psychiatrica Scandinavica. 56(4). 319–334. 9 indexed citations
7.
Lehmann, Jörgen. (1974). [Serum tryptophan in cases with senile dementia, parkinsonism and normal cases].. PubMed. 71(13). 1285–6. 1 indexed citations
8.
Lehmann, Jörgen. (1973). TRYPTOPHAN MALABSORPTION IN LEVODOPA‐TREATED PARKINSONIAN PATIENTS. Acta Medica Scandinavica. 194(1-6). 181–189. 29 indexed citations
9.
Lehmann, Jörgen. (1972). Prevention of the Precipitation of Urinary Salts with p-Aminosalicylic Acid and Closely Related Substances: In Vivo Experiments. Scandinavian Journal of Urology and Nephrology. 6(1). 76–80.
10.
Lehmann, Jörgen. (1971). Light- a Source of Error in the Fluorometric Determination of Tryptophan. Scandinavian Journal of Clinical and Laboratory Investigation. 28(1). 49–55. 57 indexed citations
11.
Lehmann, Jörgen. (1971). LEVODOPA AND DEPRESSION IN PARKINSONISM. The Lancet. 297(7690). 140–140. 10 indexed citations
12.
Lehmann, Jörgen. (1969). An Improved Fluorometric Method for the Determination of Tryptophan in Urine Using Sephadex G-10 Extraction. Scandinavian Journal of Clinical and Laboratory Investigation. 23(3). 249–254. 7 indexed citations
13.
Lehmann, Jörgen. (1968). Fluorometric Determination of Tryptophan in Normal and Carcinoid Blood and Urine. Errors in Urine Analysis. Scandinavian Journal of Clinical and Laboratory Investigation. 22(1). 72–78. 9 indexed citations
14.
Lehmann, Jörgen. (1968). On the Conservation and Determination of 5-Hydroxytryptamine in Blood. Scandinavian Journal of Clinical and Laboratory Investigation. 21(4). 369–374. 1 indexed citations
15.
Ernest, Ingrid, et al.. (1964). ROUTINE DETERMINATIONS OF 17-KETOSTEROIDS AND PORTER-SILBER CHROMOGENS COMPARED WITH THE CHROMATOGRAPHIC MEASUREMENT OF GROUPED AND INDIVIDUAL STEROIDS. European Journal of Endocrinology. 46(4). 552–562. 8 indexed citations
16.
Lehmann, Jörgen. (1962). A New Reagent for the Decoloration and Deproteinization of Urine for the Polarimetric Determination of Glucose. Scandinavian Journal of Clinical and Laboratory Investigation. 14(2). 212–216. 1 indexed citations
17.
Ekman, H, et al.. (1961). PLASMA 17-HYDROXYCORTICOSTEROIDS IN CUSHING'S SYNDROME*. The Journal of Clinical Endocrinology & Metabolism. 21(6). 684–694. 40 indexed citations
18.
Lehmann, Jörgen. (1959). Historical Notes on the Early Development of Anticoagulant Therapy with Dicumarol in Sweden. Circulation. 19(1). 122–126. 1 indexed citations
19.
Lehmann, Jörgen. (1952). Comments on the determination of para-aminosalicylic acid (pas) with dimethylaminobenzaldehyde. Scandinavian Journal of Clinical and Laboratory Investigation. 4(2). 142–151. 1 indexed citations
20.
Lehmann, Jörgen. (1951). A Micromethod for the Determination of Para-Aminosalicylic Acid (Pas) in Blood, Urine and Other Biological Fluids. Scandinavian Journal of Clinical and Laboratory Investigation. 3(4). 306–310. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026